[go: up one dir, main page]

MX2007012785A - Formulaciones de vacuna novedosas. - Google Patents

Formulaciones de vacuna novedosas.

Info

Publication number
MX2007012785A
MX2007012785A MX2007012785A MX2007012785A MX2007012785A MX 2007012785 A MX2007012785 A MX 2007012785A MX 2007012785 A MX2007012785 A MX 2007012785A MX 2007012785 A MX2007012785 A MX 2007012785A MX 2007012785 A MX2007012785 A MX 2007012785A
Authority
MX
Mexico
Prior art keywords
oil
water
ionic
oav
immunogen
Prior art date
Application number
MX2007012785A
Other languages
English (en)
Inventor
Alexis Guy Andre Parisot
Stephanie Desgouilles-Blechet
Catherine Charreyre
Claude Jean Marie Roulet
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of MX2007012785A publication Critical patent/MX2007012785A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

La presente invencion se relaciona a emulsiones de aceite en agua, su uso como adyuvantes, y composiciones farmaceuticas, inmunologicas o de vacuna que pueden comprender las mismas. En una modalidad, la emulsion de aceite en agua (OAV) puede comprender una solucion acuosa que contiene un inmunogeno un aceite mineral, un alcohol graso etoxilado lipofilico, no ionico y un surfactante hidrofilico no ionico. En otra modalidad, la emulsion de aceite en agua (OAV) puede comprender una solucion acuosa que contiene un inmunogeno, un surfactante lipofilico no ionico, un aceite mineral y un alcohol graso etoxilado hidrofilico, no ionico. La presente invencion tambien abarca un metodo para hacer una composicion de vacuna usando el adyuvante de la presente invencion, la composicion de vacuna asi obtenida y metodos de uso.
MX2007012785A 2005-04-15 2006-04-13 Formulaciones de vacuna novedosas. MX2007012785A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/107,000 US7691368B2 (en) 2005-04-15 2005-04-15 Vaccine formulations
PCT/US2006/013936 WO2006113373A2 (en) 2005-04-15 2006-04-13 Novel vaccine formulations

Publications (1)

Publication Number Publication Date
MX2007012785A true MX2007012785A (es) 2008-01-11

Family

ID=36950184

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007012785A MX2007012785A (es) 2005-04-15 2006-04-13 Formulaciones de vacuna novedosas.

Country Status (24)

Country Link
US (1) US7691368B2 (es)
EP (2) EP1888107B1 (es)
JP (1) JP5093902B2 (es)
KR (1) KR101292874B1 (es)
CN (1) CN101184501A (es)
AR (1) AR053360A1 (es)
AU (2) AU2006236711B2 (es)
BR (1) BRPI0610633B1 (es)
CA (1) CA2604432C (es)
CY (1) CY1113104T1 (es)
DK (1) DK1888107T3 (es)
ES (1) ES2389377T3 (es)
IL (1) IL186600A (es)
MX (1) MX2007012785A (es)
MY (1) MY144189A (es)
NZ (2) NZ562663A (es)
PL (1) PL1888107T3 (es)
PT (1) PT1888107E (es)
RU (1) RU2422155C2 (es)
SI (1) SI1888107T1 (es)
TW (1) TWI376232B (es)
UA (1) UA94404C2 (es)
WO (1) WO2006113373A2 (es)
ZA (1) ZA200708634B (es)

Families Citing this family (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
UA95458C2 (ru) * 2005-09-09 2011-08-10 Интервет Интернешонал Б.В. Вакцина против pcv-2 у mda-положительных поросят
EP2368572B1 (en) 2005-11-04 2020-03-04 Seqirus UK Limited Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
US20110180430A1 (en) 2005-11-04 2011-07-28 Novartis Vaccines And Diagnostics Srl Adjuvanted influenza vaccines including cytokine-inducing agents
US20090304742A1 (en) 2005-11-04 2009-12-10 Novartis Vaccines And Diagnostics Srl Influenza vaccines with reduced amount of emulsion adjuvant
PL1968630T3 (pl) 2005-12-29 2018-08-31 Boehringer Ingelheim Vetmedica, Inc. Multiwalentne immunogenne kompozycje PCV2
PT3127551T (pt) 2005-12-29 2020-10-09 Boehringer Ingelheim Animal Health Usa Inc Composição imunogénica de pcv2 para atenuar os sintomas clínicos em porcos
FR2896162B1 (fr) 2006-01-13 2008-02-15 Sanofi Pasteur Sa Emulsion huile dans eau thermoreversible
MX2008011247A (es) * 2006-03-03 2008-09-11 Merial Ltd Vacuna de micoplasma hyopneumoniae.
CA2646349A1 (en) 2006-03-24 2007-10-04 Novartis Vaccines And Diagnostics Gmbh & Co Kg Storage of influenza vaccines without refrigeration
GB0614460D0 (en) 2006-07-20 2006-08-30 Novartis Ag Vaccines
CA3016948A1 (en) 2006-09-11 2008-03-20 Seqirus UK Limited Making influenza virus vaccines without using eggs
US20100136060A1 (en) * 2006-11-22 2010-06-03 Boehringer Ingelheim Vetmedica, Inc. Methods of reducing porcine circovirus-associated disease outbreaks
PT2121011E (pt) 2006-12-06 2014-07-31 Novartis Ag Vacinas compreendendo um antigénio a partir de quatro estirpes do vírus da gripe
EP2859900A1 (en) * 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
CN101558169B (zh) * 2006-12-15 2017-08-04 贝林格尔.英格海姆维特梅迪卡有限公司 以pcv2抗原治疗猪
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
SG10201913741YA (en) 2007-04-06 2020-03-30 Takeda Vaccines Inc Methods and compositions for live attenuated viruses
NZ582595A (en) 2007-06-27 2012-07-27 Novartis Ag Low-additive influenza vaccines
US20090017064A1 (en) * 2007-07-10 2009-01-15 Wyeth Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
US7829274B2 (en) * 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
ATE553774T1 (de) 2007-10-19 2012-05-15 Novartis Ag Meningokokkenimpfstoffformulierungen
GB0810305D0 (en) 2008-06-05 2008-07-09 Novartis Ag Influenza vaccination
CN101903041A (zh) * 2007-12-21 2010-12-01 辉瑞大药厂 经热处理的菌苗,及由这些经热处理的菌苗制备的乳剂疫苗
JP2011508595A (ja) * 2007-12-31 2011-03-17 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド 外来性アミノ酸の挿入を含むｐｃｖ２ｏｒｆ２ウイルス様粒子
EP2242511A4 (en) * 2008-01-23 2012-10-24 Boehringer Ingelheim Vetmed IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS
EP2268309B1 (en) 2008-03-18 2015-01-21 Novartis AG Improvements in preparation of influenza virus vaccine antigens
US9642908B2 (en) * 2008-07-30 2017-05-09 University Of Kentucky Research Foundation Equine disease model for herpesvirus neurologic disease and uses thereof
WO2010032138A2 (en) 2008-09-18 2010-03-25 Novartis Ag Vaccine adjuvant combinations
EP3168307B1 (en) 2008-11-28 2020-07-15 Boehringer Ingelheim Animal Health USA Inc. Recombinant avian influenza vaccine and uses thereof
AU2010212548A1 (en) 2009-02-10 2011-09-15 Novartis Ag Influenza vaccines with increased amounts of H3 antigen
ES2552383T3 (es) 2009-02-10 2015-11-27 Novartis Ag Regímenes de vacuna de la gripe para cepas asociadas a pandemias
CN105727281A (zh) 2009-02-10 2016-07-06 诺华股份有限公司 具有减少量的角鲨烯的流感疫苗
JP2012519482A (ja) 2009-03-06 2012-08-30 ノバルティス アーゲー クラミジア抗原
EP2228054A1 (en) * 2009-03-13 2010-09-15 ITALFARMACO S.p.A. Riluzole aqueous suspensions
NZ595291A (en) 2009-03-24 2013-08-30 Novartis Ag Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
MX2011010735A (es) 2009-04-14 2012-01-25 Novartis Ag Composiciones para inmunizacion contra staphylococcus aureus.
BRPI1010679B1 (pt) * 2009-05-19 2020-09-24 Bioproperties Pty Ltd Cepa de vacina de mycoplasma hyopneumoniae sensível à temperatura e aplicações da mesma, composiçao de vacina, método de preparaçao e uso da mesma
ES2394797T3 (es) 2009-05-21 2013-02-05 Novartis Ag Genética inversa usando promotores no endógenos de pol l
EA201171491A1 (ru) 2009-05-29 2012-07-30 Новартис Аг Анализы гемагглютининов вируса гриппа
US10988511B2 (en) 2009-07-07 2021-04-27 Glaxosmithkline Biologicals Sa Conserved Escherichia bacterial IG-like domain (group 1) protein (ORF405) immunogens
US8871214B2 (en) 2009-07-16 2014-10-28 Novartis Ag Detoxified Escherichia coli immunogens
US9085610B2 (en) * 2009-07-31 2015-07-21 National Research Council Of Canada H. pylori lipopolysaccharide outer core epitope
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
PH12012500477A1 (en) * 2009-09-10 2012-10-22 Merial Inc New vaccine formulations comprising saponin-containing adjuvants
KR20120081587A (ko) 2009-09-10 2012-07-19 노파르티스 아게 기도 질병에 대한 조합 백신
GB0917003D0 (en) 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Purification of bacterial vesicles
GB0917002D0 (en) 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Improved shigella blebs
WO2011039631A2 (en) 2009-09-30 2011-04-07 Novartis Ag Expression of meningococcal fhbp polypeptides
EA023811B1 (ru) 2009-10-20 2016-07-29 Новартис Аг Способ получения вируса с использованием конструкции, кодирующей вирусную рнк
GB0918392D0 (en) 2009-10-20 2009-12-02 Novartis Ag Diagnostic and therapeutic methods
GB0919690D0 (en) 2009-11-10 2009-12-23 Guy S And St Thomas S Nhs Foun compositions for immunising against staphylococcus aureus
JP5781542B2 (ja) 2009-12-30 2015-09-24 ノバルティス アーゲー Ｅ．ｃｏｌｉキャリアタンパク質に結合体化した多糖免疫原
GB201003333D0 (en) 2010-02-26 2010-04-14 Novartis Ag Immunogenic proteins and compositions
WO2012020326A1 (en) 2010-03-18 2012-02-16 Novartis Ag Adjuvanted vaccines for serogroup b meningococcus
FR2957933B1 (fr) * 2010-03-24 2012-04-27 Seppic Sa Vaccin vivant pour maladies aviaires
GB201005625D0 (en) 2010-04-01 2010-05-19 Novartis Ag Immunogenic proteins and compositions
EP2556151A1 (en) 2010-04-07 2013-02-13 Novartis AG Method for generating a parvovirus b19 virus-like particle
SG184804A1 (en) 2010-04-30 2012-11-29 Temasek Life Sciences Lab Ltd Universal vaccine against h5n1 lineages
WO2011141443A1 (en) * 2010-05-11 2011-11-17 Intervet International B.V. Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
AU2011254204B2 (en) 2010-05-21 2015-08-20 Seqirus UK Limited Influenza virus reassortment method
GB201009861D0 (en) 2010-06-11 2010-07-21 Novartis Ag OMV vaccines
US10478483B2 (en) 2010-06-25 2019-11-19 Glaxosmithkline Biologicals Sa Combinations of meningococcal factor H binding proteins
US20130171185A1 (en) 2010-07-06 2013-07-04 Ethan Settembre Norovirus derived immunogenic compositions and methods
GB201017519D0 (en) 2010-10-15 2010-12-01 Novartis Vaccines Inst For Global Health S R L Vaccines
WO2012072769A1 (en) 2010-12-01 2012-06-07 Novartis Ag Pneumococcal rrgb epitopes and clade combinations
WO2012117377A1 (en) 2011-03-02 2012-09-07 Novartis Ag Combination vaccines with lower doses of antigen and/or adjuvant
ES2687129T3 (es) 2011-07-25 2018-10-23 Glaxosmithkline Biologicals Sa Composiciones y métodos para evaluar la inmunogenicidad funcional de vacunas contra parvovirus
TR201909110T4 (tr) 2011-09-14 2019-07-22 Glaxosmithkline Biologicals Sa Sakarit-protein glikokonjugatları yapmaya yönelik yöntemler.
WO2013057715A1 (en) 2011-10-20 2013-04-25 Novartis Ag Adjuvanted influenza b virus vaccines for pediatric priming
EP2791680B1 (en) 2011-12-12 2015-12-09 Novartis AG Assay for influenza virus hemagglutinins
CN104023744A (zh) 2011-12-23 2014-09-03 诺华股份有限公司 用于针对金黄色葡萄球菌免疫的稳定组合物
US9446117B2 (en) * 2012-02-14 2016-09-20 Merial, Inc. Rotavirus subunit vaccines and methods of making and use thereof
EP2820126B1 (en) 2012-03-02 2017-05-17 Seqirus UK Limited Influenza virus reassortment
US20150161359A1 (en) 2012-06-04 2015-06-11 Novartis Ag Methods for safety testing
PL2890394T3 (pl) 2012-08-31 2019-12-31 Glaxosmithkline Biologicals Sa Stabilizowane białka do immunizacji przeciw staphylococcus aureus
JP2015528456A (ja) 2012-08-31 2015-09-28 ノバルティス アーゲー Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓに対する免疫化のための安定化されたタンパク質
WO2014039978A2 (en) 2012-09-10 2014-03-13 Szathmary Dr Susan Vaccine to prevent mycoplasmal infection in waterfowl
EP2897635A1 (en) 2012-09-18 2015-07-29 Novartis AG Outer membrane vesicles
CN105307684A (zh) 2012-10-02 2016-02-03 葛兰素史密丝克莱恩生物有限公司 非直链糖缀合物
GB201218195D0 (en) 2012-10-10 2012-11-21 Istituto Zooprofilattico Sperimentale Delle Venezie Composition
SG11201504258RA (en) 2012-11-30 2015-07-30 Glaxosmithkline Biolog Sa Pseudomonas antigens and antigen combinations
KR20150110494A (ko) 2012-12-03 2015-10-02 노파르티스 아게 재배열 인플루엔자 a 바이러스
CA2905612A1 (en) 2013-03-13 2014-09-18 Novartis Ag Influenza virus reassortment
EP2994162B1 (en) 2013-05-08 2021-04-07 Pharmgate Biologics Inc. Vaccine for pcv2 and mycoplasma
CN105828835A (zh) 2013-05-10 2016-08-03 诺华股份有限公司 避免流感疫苗中的发作性嗜睡病风险
DE202013005130U1 (de) 2013-06-05 2013-09-10 Novartis Ag Influenza Virus Reassortierung
DE202013005100U1 (de) 2013-06-05 2013-08-26 Novartis Ag Influenza Virus Reassortierung
KR20160014657A (ko) 2013-06-06 2016-02-11 노파르티스 아게 인플루엔자 바이러스 재배열
KR102409183B1 (ko) 2013-10-02 2022-06-15 베링거 인겔하임 애니멀 헬스 유에스에이 인크. Ｐｃｖ2 ｏｒｆ2 단백질 변이체 및 이로 이루어진 바이러스 유사 입자
BR112016012435A8 (pt) 2013-12-03 2018-01-30 Intervet Int Bv vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
CN103751779A (zh) * 2014-02-25 2014-04-30 中国农业科学院上海兽医研究所 O型口蹄疫多肽的泊洛沙姆凝胶佐剂
KR102297357B1 (ko) 2014-03-26 2021-09-02 글락소스미스클라인 바이오로지칼즈 에스.에이. 돌연변이 스태필로코쿠스 항원
WO2015179412A1 (en) 2014-05-19 2015-11-26 Merial, Inc. Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (pedv)
US20150359880A1 (en) * 2014-06-16 2015-12-17 Biomune Company Dual adjuvant vaccine compositions, preparation and uses
CN105288614A (zh) * 2014-06-18 2016-02-03 潘皓 一种疫苗组合物及其制备方法
JP2015120709A (ja) * 2015-01-09 2015-07-02 ラボラトリオ アヴィメキシコ エスエー ディーイー シーヴィーＬａｂｏｒａｔｏｒｉｏ Ａｖｉ−Ｍｅｘ，Ｓ．Ａ． Ｄｅ Ｃ．Ｖ． 遺伝子組み換え不活性化ウィルスベクターワクチン
AU2016282761B2 (en) 2015-06-26 2019-07-04 Boehringer Ingelheim Animal Health USA Inc. Inactivated canine influenza vaccines and methods of making and uses thereof
BR112017028011A2 (en) 2015-06-26 2018-08-28 Seqirus UK Limited antigenically matched influenza vaccines
WO2017005880A1 (en) 2015-07-07 2017-01-12 Seqirus UK Limited Influenza potency assays
BR112018007093A2 (pt) 2015-10-08 2019-01-15 Pasteur Institut vacina heteróloga atentada viva para leptospirose
RU2714428C2 (ru) 2015-11-23 2020-02-14 Мериал, Инк. Слитые белки fmdv-e2 и их применение
TWI760322B (zh) 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途
JOP20190088A1 (ar) 2016-10-21 2019-04-21 Us Agriculture نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها
JP7174698B2 (ja) * 2016-11-29 2022-11-17 インターベット インターナショナル ベー． フェー． ブタワクチン
BR112019012280A2 (pt) 2016-12-14 2019-11-26 Boehringer Ingelheim Animal Health Usa Inc vetores recombinantes de hvt que expressam múltiplos antígenos de patógenos aviários e vacinas compreendendo os mesmos
WO2020078958A1 (en) 2018-10-16 2020-04-23 Intervet International B.V. Stable emulsions of bacterial antigens
FR3092754B1 (fr) * 2019-02-18 2022-06-03 Total Marketing Services Composition adjuvante pour vaccin
JP2023502650A (ja) 2019-11-18 2023-01-25 セキラス ピーティーワイ リミテッド 遺伝子再集合インフルエンザウイルスを産生するための方法
CN113546162B (zh) * 2021-05-31 2023-07-18 江苏省农业科学院 一种支原体疫苗及其制备方法
CN120529916A (zh) 2022-12-22 2025-08-22 法国诗华动物保健公司 油佐剂组合物和包含此类油佐剂组合物的疫苗乳液

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250289A (en) * 1987-07-24 1993-10-05 The Boots Company Plc Sunscreen compositions
US5376369A (en) * 1987-11-03 1994-12-27 Syntex (U.S.A.) Inc. Vaccine adjuvant
PL155558B1 (pl) * 1988-01-28 1991-12-31 Inst Ciezkiej Syntezy Orga Sposób wytwarzania kompozycji emulgującej
AU657907B2 (en) 1990-05-29 1995-03-30 Wyeth Holdings Corporation Mycoplasma hyopneumoniae vaccine
US6197311B1 (en) * 1991-07-25 2001-03-06 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses
US5846805A (en) 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
US5338543A (en) 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5695766A (en) 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
NZ261992A (en) 1993-02-08 1996-06-25 Bayer Ag Porcine reproductive and respiratory syndrome virus, cultures, attenuated forms and vaccines thereof
FR2723740B1 (fr) 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
US5985177A (en) 1995-12-14 1999-11-16 Shiseido Co., Ltd. O/W/O type multiple emulsion and method of preparing the same
US5866401A (en) 1996-03-01 1999-02-02 Schering Corporation Porcine reproductive and respiratory syndrome vaccine
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
RU2233175C2 (ru) * 2002-06-25 2004-07-27 Всероссийский научно-исследовательский институт птицеводства Вакцинный препарат для профилактики аденовирусного гепатита с включениями - гидроперикардита кур
CN1852735B (zh) * 2003-07-24 2011-05-11 梅瑞尔有限公司 包含水包油乳液的疫苗制剂
US9390965B2 (en) 2013-12-20 2016-07-12 Taiwan Semiconductor Manufacturing Co., Ltd. Air-gap forming techniques for interconnect structures

Also Published As

Publication number Publication date
CY1113104T1 (el) 2016-04-13
US7691368B2 (en) 2010-04-06
JP5093902B2 (ja) 2012-12-12
MY144189A (en) 2011-08-15
RU2007142202A (ru) 2009-05-20
AR053360A1 (es) 2007-05-02
KR101292874B1 (ko) 2013-08-05
AU2006236711B2 (en) 2010-07-29
UA94404C2 (ru) 2011-05-10
TWI376232B (en) 2012-11-11
CA2604432A1 (en) 2006-10-26
HK1116085A1 (en) 2008-12-19
IL186600A0 (en) 2008-01-20
DK1888107T3 (da) 2012-07-23
BRPI0610633A2 (pt) 2010-07-13
SI1888107T1 (sl) 2012-09-28
ZA200708634B (en) 2008-10-29
RU2422155C2 (ru) 2011-06-27
PL1888107T3 (pl) 2012-11-30
EP1888107A2 (en) 2008-02-20
CN101184501A (zh) 2008-05-21
AU2006236711A1 (en) 2006-10-26
AU2010206041A1 (en) 2010-08-19
NZ562663A (en) 2010-04-30
AU2010206041B2 (en) 2012-08-02
TW200716165A (en) 2007-05-01
US20060233831A1 (en) 2006-10-19
JP2008536860A (ja) 2008-09-11
IL186600A (en) 2014-05-28
EP1888107B1 (en) 2012-06-13
WO2006113373A2 (en) 2006-10-26
BRPI0610633B1 (pt) 2021-07-20
ES2389377T3 (es) 2012-10-25
CA2604432C (en) 2013-06-11
PT1888107E (pt) 2012-07-26
NZ584420A (en) 2011-11-25
KR20070122550A (ko) 2007-12-31
EP2422809A1 (en) 2012-02-29
WO2006113373A3 (en) 2007-02-01

Similar Documents

Publication Publication Date Title
MX2007012785A (es) Formulaciones de vacuna novedosas.
SG163584A1 (en) Thermoreversible immuno-adjuvant emulsion
AR121096A2 (es) Formulaciones de vacunas que comprenden adyuvantes con saponina
HRP20080235T3 (hr) Formulacija vakcine koja sadrži emulziju ulje-u-vodi
MA30298B1 (fr) Composition
CL2008001383A1 (es) Composición lactea o de sustituto lacteo aireada y liofilizada que comprende un ingrediente lacteo o substituto lacteo, un emulsificante, un mejorador de la viscosidad; y metodo para preparar dicha composicion.
CO6251369A2 (es) Vacuna de influenza de emulsion de aceite en agua
CL2010000234A1 (es) Combinacion fungicida que comprende fluoxaestrobin y al menos un imidazol seleccionado entre cyzofamid, prochloraz, triazoxide o pefurazoate y usos de la misma para combatir hongos fitopatogenos y en la obtencion de composiciones fungicidas que comprenden ademas agentes extendedores y/o surfactantes (divisional de 2673-2005)
MX2009003325A (es) Vacuna que comprende un adyuvante de emulsion de aceite en agua.
MA30624B1 (fr) Vaccin anti-grippal
TW200513193A (en) Fat or oil composition
ATE365538T1 (de) O/w emulsion
AR075437A1 (es) Composicion inmunogenica que comprende al menos un antigeno del virus del dengue inactivado y un adyuvante sin aluminio, metodo para producir dicha vacuna y su uso para preparar un medicamento
AR067084A1 (es) Dispersion solida que contiene revaprazan y procedimiento para la preparacion de la misma. composicion farmaceutica.
NO20070746L (no) Anvendelse av fosfaterte alkanoler som dispergente , emulgatorer, hydrotroper, fuktmidler og kompatabilitetsstoffer i blandinger for jordbruket.
MX384242B (es) Composicion de peroxido organico sin agente coloide.
WO2013007637A3 (en) Cosmetic compositions in the form of water-in-oil emulsions including a jasmonic acid derivative and a silicone surfactant
EA201001478A1 (ru) Вакцина
CO2023013231A2 (es) Composiciones de espirotetramato que comprenden adyuvantes
JP2018131425A5 (es)
MX2020001623A (es) Sistema emulsionante, producto de cuidado personal, metodo y uso.
TH122323A (th) สูตรผสมวัคซีนชนิดใหม่
TH68146B (th) สูตรผสมวัคซีนชนิดใหม่
WO2002013856A3 (de) W/0 emulsion adjuvanszusammensetzungen für impstoffen
UY29523A1 (es) Formulaciones de vacunas novedosas

Legal Events

Date Code Title Description
FG Grant or registration